Plasma transforming growth factor β levels in breast cancer patients

Oncology Reports

Volumn 5, Issue 2, 1998, Pages 485-488

  Sminia, Peter ^a   Barten, Angeliqué D ^a   Van Waarde, Maria A W H ^b   Vujaskovic, Zeljko ^b   Van Tienhoven, Geertjan ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Bioassay; Breast cancer; Transforming growth factor

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; TUMOR MARKER;

ADVANCED CANCER; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER STAGING; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; EXCISION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE DIAGNOSIS; STATISTICAL ANALYSIS;

ANIMALS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CARCINOMA, MEDULLARY; CELLS, CULTURED; FEMALE; HUMANS; MINK; NEOPLASM PROTEINS; NEOPLASM STAGING; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031935536     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Sporn MB and Roberts AB: Transforming growth factor β: Recent progress and new challenges. J Cell Biol 119: 1017-1021, 1992.
2. Arrick BA, Lopez AR, Elfman F, Ebner R, Damsky CH and Derynck R: Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor β1. J Cell Biol 118: 715-726, 1992.
3. Walker RA and Gallacher B: Determination of transforming growth factor β1 mRNA expression in breast carcinomas by in situ hybridization. J Pathol 177: 123-127, 1995.
4. Arteaga CL, Dugger TC, Winnier AR and Forbes JT: Evidence for a positive role of transforming growth factor-β in human breast cancer cell tumorigenesis. J Cell Biochem 17: 187-193, 1993.
5. Welch DR, Fabra A and Nakajima M: Transforming growth factor β stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc Natl Acad Sci USA 87: 7678-7682, 1990.
6. Dalal BL, Keown PA and Greenberg AH: Immunocytochemical localization of secreted transforming growth factor-β1 to the advancing edges of primary tumors and lymph node metastases of human mammary carcinoma. Am J Pathol 143: 381-389, 1993.
7. Ivanovic V, Melman A, Davis-Joseph B, Valcic M and Geliebter J: Elevated plasma levels of TGFβ1 in patients with invasive prostate cancer. Nat Med 1: 282-283, 1995.
8. Kong F-M, Washington MK, Jirtle RL and Anscher MS: Plasma transforming growth factor-β1 reflects disease status in patients with lung cancer after radiotherapy: a possible tumor marker. Lung Cancer 16: 47-59, 1996.
9. Tada T, Yabu K and Kabayashi S: Detection of active form of transforming growth factor β in cerebrospinal fluid of patients with glioma. Jpn J Cancer Res 84: 544-548, 1993.
10. Kong F-M, Anscher MS, Murase T, Abbott BD, Iglehart D and Jirtle RL: Elevated plasma transforming growth factor-β1 levels in breast cancer patients decrease after surgical removal of the tumor. Ann Surg 222: 155-162, 1995.
11. Wakefield LM, Letterio JJ, Chen T, Danielpour D, Allison RSH, Pai LH, Denicoff AM, Noone MH, Cowan KH, O'Shaughnessy JA and Sporn MB: Transforming growth factor-β1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer. Clin Cancer Res 1: 129-136, 1995.
12. Abe M, Harpel JG, Metz CN, Nunes I, Loskutoff DJ and Rifkin DB: An assay for transforming growth factor-β using cells transfected with a plasminogen activator inhibitor-1 promoter luciferase construct. Anal Biochem 216: 276-284, 1994.
13. Van Waarde MAWH, Van Assen AJ, Kampinga HH, Konings ATW and Vujaskovic Z: Quantification of transforming growth factor-β in biological material using cells transfected with plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem 247: 45-51, 1997.
14. Anscher MS, Peter WP, Reisenbichler H, Petros WP and Jirtle RL: Transforming growth factor β as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med 328: 1592-1598, 1993.
15. Murase T, Anscher MS, Petros WP, Peters WP and Jirtle RL: Changes in plasma transforming growth factor β in response to high-dose chemotherapy for stage II breast cancer: possible implications for the prevention of hepatic veno-occlusive disease and pulmonary drug toxicity. Bone Marrow Transplant 15: 173-178, 1995.
16. Auvinen P, Lipponen P, Johansson R and Syrjänen K: Prognostic significance of TGFβ-1 and TGFβ-2 expressions in female breast cancer. Anticancer Res 15: 2627-2632, 1995.
17. Anscher MS, Kong F-M, Marks LB, Bentel GC and Jirtle RL: Changes in plasma transforming growth factor β during radiotherapy and the risk of symptomatic radiation-induced pneumonitis. Int J Radiat Oncol Biol Phys 37: 253-258, 1997.
18. Vujaskovic Z, Down JD, Van Waarde MAWH, Van Assen AJ, Szabo BG and Konings AWT: Plasma TGFβ level in rats after hemithoracic irradiation. Radiother Oncol 44: 41-43, 1997.
19. Murray PA, Barrett-Lee P, Travers M, Luqmani L, Powles T and Coombes RC: The prognostic significance of transforming growth factors in human breast cancer. Br J Cancer 67: 1408-1412, 1993.
20. Christeli E, Zoumpourlis V, Kiaris H, Ergazaki M, Vassilaros S and Spandidos DA: TGF-β1 overexpression in breast cancer: Correlation with clinicopathological data. Oncol Rep 3: 1115-1118, 1996.